Latest filing published 11 Mar 2024 for Sana Biotechnology, Inc., €216k. Read the official filing
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
This profile gathers the share dealings of Patrick Y. Yang across 2 companies, led by Codexis, Inc. and Sana Biotechnology, Inc. The record holds 6 filings, for trades running from 15 June 2021 to 8 March 2024.
The open-market side counts 1 purchase for €185k alongside 3 sales for €556k. On balance, insiders were net sellers of €371k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 2 share grants. In 2024 alone, the filings show no purchases and 1 sale.
Most recently, on 11 March 2024, the filings show an open-market sale worth €216k in Sana Biotechnology, Inc. The latest purchase dates back some time: it was published 1,671 days ago, on 22 March 2022. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations